Global Head and Neck Cancer Radiation Therapies and Epidemiology - 2016

  • ID: 3692206
  • Report
  • Region: Global
  • 110 pages
  • Epipatients
1 of 3
The latest survey Global Head and Neck Cancer Radiation Therapies and Epidemiology – 2016, provides insights into total Head and Neck Cancer patients on radiation therapies in top 7 markets, Head and Neck Cancer treatable patients, and Head and Neck Cancer epidemiology in top 7 markets. Epipatients conducted an online survey with Head and Neck Cancer specialists, oncologists, and Head and Neck Cancer patients to identify the Head and Neck Cancer patients in top 7 markets who were treated by radiation therapies. The research also identifies total Head and Neck Cancer patients’ on radiation therapies by Head and Neck Cancer stages.
Head and Neck cancer patients undergo radiation therapy as a part of their treatment. This study accurately determines and forecast Head and Neck Cancer patients who were on radiation therapies in a given year. This research also provides insights into Head and Neck Cancer epidemiology including Head and Neck Cancer incidence and Head and Neck Cancer prevalence by Head and Neck Cancer stages I-IV.

Key Questions Answered:
- Countries: US, Japan, Germany, France, Italy, Spain, UK
- Head and Neck Cancer Incidence in top 7 markets by staging – Stage I, Stage II, Stage III, and Stage IV
- Head and Neck Cancer Prevalence in top 7 markets (10-year) by staging – Stage I, Stage II, Stage III, and Stage IV
- Head and Neck Cancer Treatable Patients in top 7 markets by staging – Stage I, Stage II, Stage III, and Stage IV
- Head and Neck Cancer Patients on radiation therapies by stages – Stage I, Stage II, Stage III, and Stage IV
- Base Year – 2015, Historic from 2010 and forecast to 2025

Key Benefits:
This research will help analysts, healthcare providers, pharmaceutical companies, epidemiologists, clinical research organizations, universities, government agencies, and insurers to determine their study population. This research will help executives estimate Head and Neck Cancer market potential, Head and Neck Cancer radiation therapies market potential, assess unmet need, patient share, market share, develop forecasting models, and build patient-based health management frameworks. The data presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Methodology
2. Head and Neck Cancer Patients Globally by Stages
2.1. Incidence
2.2. Prevalence
2.3. Treatable Patients
2.4. Patients on Radiation Therapies
3. Head and Neck Cancer Patients in Germany by Stages
3.1. Incidence
3.2. Prevalence
3.3. Treatable Patients
3.4. Patients on Radiation Therapies
4. Head and Neck Cancer Patients in France by Stages
4.1. Incidence
4.2. Prevalence
4.3. Treatable Patients
4.4. Patients on Radiation Therapies
5. Head and Neck Cancer Patients in Italy by Stages
5.1. Incidence
5.2. Prevalence
5.3. Treatable Patients
5.4. Patients on Radiation Therapies
6. Head and Neck Cancer Patients in Spain by Stages
6.1. Incidence
6.2. Prevalence
6.3. Treatable Patients
6.4. Patients on Radiation Therapies
7. Head and Neck Cancer Patients in UK by Stages
7.1. Incidence
7.2. Prevalence
7.3. Treatable Patients
7.4. Patients on Radiation Therapies
8. Head and Neck Cancer Patients in Japan by Stages
8.1. Incidence
8.2. Prevalence
8.3. Treatable Patients
8.4. Patients on Radiation Therapies
9. Head and Neck Cancer Patients in US by Stages
9.1. Incidence
9.2. Prevalence
9.3. Treatable Patients
9.4. Patients on Radiation Therapies
10. Glossary

1. Head and Neck Cancer Incidence by Stages, Global, 2010 - 2025
2. Head and Neck Cancer Prevalence by Stages, Global, 2010 - 2025
3. Head and Neck Cancer Treatable Patients by Stages, Global, 2010 - 2025
4. Total Head and Neck Cancer Patients on Radiation Therapies by Stages, Global, 2010 – 2025
5. Head and Neck Cancer Incidence by Stages, Germany, 2010 - 2025
6. Head and Neck Cancer Prevalence by Stages, Germany, 2010 - 2025
7. Head and Neck Cancer Treatable Patients by Stages, Germany, 2010 - 2025
8. Total Head and Neck Cancer Patients on Radiation Therapies by Stages, Germany, 2010 - 2025
9. Head and Neck Cancer Incidence by Stages, France, 2010 - 2025
10. Head and Neck Cancer Prevalence by Stages, France, 2010 - 2025
11. Head and Neck Cancer Treatable Patients by Stages, France, 2010 - 2025
12. Total Head and Neck Cancer Patients on Radiation Therapies by Stages, France, 2010 - 2025
13. Head and Neck Cancer Incidence by Stages, Italy, 2010 - 2025
14. Head and Neck Cancer Prevalence by Stages, Italy, 2010 - 2025
15. Head and Neck Cancer Treatable Patients by Stages, Italy, 2010 - 2025
16. Total Head and Neck Cancer Patients on Radiation Therapies by Stages, Italy, 2010 - 2025
17. Head and Neck Cancer Incidence by Stages, Spain, 2010 - 2025
18. Head and Neck Cancer Prevalence by Stages, Spain, 2010 - 2025
19. Head and Neck Cancer Treatable Patients by Stages, Spain, 2010 - 2025
20. Total Head and Neck Cancer Patients on Radiation Therapies by Stages, Spain, 2010 - 2025
21. Head and Neck Cancer Incidence by Stages, UK, 2010 - 2025
22. Head and Neck Cancer Prevalence by Stages, UK, 2010 - 2025
23. Head and Neck Cancer Treatable Patients by Stages, UK, 2010 - 2025
24. Total Head and Neck Cancer Patients on Radiation Therapies by Stages, UK, 2010 – 2025
25. Head and Neck Cancer Incidence by Stages, Japan, 2010 - 2025
26. Head and Neck Cancer Prevalence by Stages, Japan, 2010 - 2025
27. Head and Neck Cancer Treatable Patients by Stages, Japan, 2010 - 2025
28. Total Head and Neck Cancer Patients on Radiation Therapies by Stages, Japan, 2010 – 2025
29. Head and Neck Cancer Incidence by Stages, US, 2010 - 2025
30. Head and Neck Cancer Prevalence by Stages, US, 2010 - 2025
31. Head and Neck Cancer Treatable Patients by Stages, US 2010 - 2025
32. Total Head and Neck Cancer Patients on Radiation Therapies by Stages, US, 2010 - 2025

1. Head and Neck Cancer Incidence, Global, 2010 – 2025
2. Head and Neck Cancer Incidence – Stage I, Global, 2010 – 2025
3. Head and Neck Cancer Incidence – Stage II, Global, 2010 - 2025
4. Head and Neck Cancer Incidence – Stage III, Global, 2010 - 2025
5. Head and Neck Cancer Incidence – Stage IV, Global, 2010 – 2025
6. Head and Neck Cancer Prevalence, Global, 2010 - 2025
7. Head and Neck Cancer Prevalence – Stage I, Global, 2010 – 2025
8. Head and Neck Cancer Prevalence – Stage II, Global, 2010 - 2025
9. Head and Neck Cancer Prevalence – Stage III, Global, 2010 - 2025
10. Head and Neck Cancer Prevalence – Stage IV, Global, 2010 - 2025
11. Head and Neck Cancer Treatable Patients, Global, 2010 - 2025
12. Head and Neck Cancer Treatable Patients – Stage I, Global, 2010 – 2025
13. Head and Neck Cancer Treatable Patients – Stage II, Global, 2010 - 2025
14. Head and Neck Cancer Treatable Patients – Stage III, Global, 2010 - 2025
15. Head and Neck Cancer Treatable Patients – Stage IV, Global, 2010 - 2025
16. Head and Neck Cancer Patients on Radiation Therapies, Global, 2010 - 2025
17. Total Head and Neck Cancer Patients on Radiation Therapies – Stage I, Global, 2010 – 2025
18. Total Head and Neck Cancer Patients on Radiation Therapies – Stage II, Global, 2010 – 2025
19. Total Head and Neck Cancer Patients on Radiation Therapies – Stage III, Global, 2010 – 2025
20. Total Head and Neck Cancer Patients on Radiation Therapies – Stage IV, Global, 2010 – 2025
21. Head and Neck Cancer Incidence by Stages, Germany, 2010 – 2025
22. Head and Neck Cancer Prevalence by Stages, Germany, 2010 – 2025
23. Head and Neck Cancer Treatable Patients by Stages, Germany, 2010 – 2025
24. Head and Neck Cancer Patients on Radiation Therapies, Germany, 2010 - 2015
25. Head and Neck Cancer Incidence by Stages, France, 2010 – 2025
26. Head and Neck Cancer Prevalence by Stages, France, 2010 – 2025
27. Head and Neck Cancer Treatable Patients by Stages, France, 2010 – 2025
28. Head and Neck Cancer Patients on Radiation Therapies, France, 2010 – 2025
29. Head and Neck Cancer Incidence by Stages, Italy, 2010 – 2025
30. Head and Neck Cancer Prevalence by Stages, Italy, 2010 – 2025
31. Head and Neck Cancer Treatable Patients by Stages, Italy, 2010 – 2025
32. Head and Neck Cancer Patients on Radiation Therapies, Italy, 2010 – 2025
33. Head and Neck Cancer Incidence by Stages, Spain, 2010 – 2025
34. Head and Neck Cancer Prevalence by Stages, Spain, 2010 – 2025
35. Head and Neck Cancer Treatable Patients by Stages, Spain, 2010 – 2025
36. Head and Neck Cancer Patients on Radiation Therapies, Spain, 2010 - 2015
37. Head and Neck Cancer Incidence by Stages, UK, 2010 – 2025
38. Head and Neck Cancer Prevalence by Stages, UK, 2010 – 2025
39. Head and Neck Cancer Treatable Patients by Stages, UK, 2010 – 2025
40. Head and Neck Cancer Patients on Radiation Therapies, UK, 2010 – 2025
41. Head and Neck Cancer Incidence by Stages, Japan, 2010 – 2025
42. Head and Neck Cancer Prevalence by Stages, Japan, 2010 – 2025
43. Head and Neck Cancer Treatable Patients by Stages, Japan, 2010 – 2025
44. Head and Neck Cancer Patients on Radiation Therapies, Japan, 2010 – 2025
45. Head and Neck Cancer Incidence by Stages, US, 2010 – 2025
46. Head and Neck Cancer Prevalence by Stages, US, 2010 – 2025
47. Head and Neck Cancer Treatable Patients by Stages, US, 2010 – 2025
48. Head and Neck Cancer Patients on Radiation Therapies, US, 2010 - 2015
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll